CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00314444
NCT00314444N/ACompleted

Treatment for Psychogenic Movement Disorders

National Institute of Neurological Disorders and Stroke (NINDS)·observational·Posted Apr 13, 2006·Updated Jul 2, 2017

In Brief

An observational study for Movement Disorders. Completed, across 1 site.

Detailed Summary

This study will examine whether biofeedback treatment is effective in lessening or stopping movement symptoms in people with psychogenic movement disorder. People with this condition have increased or decreased movements that are not under their control and are not associated with any know problem with the nervous system. Biofeedback is a type of therapy that uses electronic instruments to monitor breathing and heart rate. This treatment has been effective in patients with anxiety and panic attacks. People 18 years of age and older diagnosed with psychogenic movement disorder may be eligible for this study. Candidates are screened with a neurological history, physical examination and psychiatric evaluation. Participants come to the NIH Clinical Center for nine 1-hour test sessions over an 8-week period for the following procedures: Week 1 (two visits): * Patients' movements are videotaped while they sit, stand and walk. * Patients train on RESPeRATE device, a computerized musical biofeedback device to help slow theirs breathing rate. The device has three components: a computerized module, earphones, and a chest strap holding a breath sensor. The patients put the elastic strap around their chest, put on the earphones, and sit in a chair. The device monitors and analyzes their breathing to create a melody composed of two distinct tones - one for inhalation and one for exhalation. Patients are instructed to match their breathing to the tones, which gradually slow until they are breathing at a slower, therapeutic rate. * Patients' breathing is monitored and analyzed for information on breathing pattern and rate. * Patients complete questionnaires on level of relaxation before and after RESPeRATE training. * Patients take the RESPeRATE device home to use for two 10-minute practice sessions per day. They complete relaxation questionnaires before and after each session. Weeks 2-7: * Patients' progress is monitored and reviewed from the previous week * Patients' breathing is monitored and analyzed for information on breathing pattern and rate. * Patients complete questionnaires on level of relaxation before and after RESPeRATE training. * Patients are observed for 10 minutes while using the RESPeRATE device. Week 8: * Patients' progress is monitored and reviewed from the previous week * Patients' breathing is monitored and analyzed for information on breathing pattern and rate. * Patients complete questionnaires on level o...

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 13, 2006
Enrollment StartApr 7, 2006
Study CompletionApr 14, 2009
TodayJul 2, 2026
Posted 20.2 years ago